AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

Search

KKR & Co LP

Suletud

SektorRahandus

125.83 0.2

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

124.57

Max

126.46

Põhinäitajad

By Trading Economics

Sissetulek

-700M

684M

Müük

-90M

3.1B

P/E

Sektori keskmine

38.177

24.598

Aktsiakasum

1.15

Dividenditootlus

0.59

Kasumimarginaal

22.008

Töötajad

4,834

EBITDA

-17M

1.5B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+9.8% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.59%

4.30%

Järgmine tulemuste avaldamine

30. juuli 2025

Järgmine dividendimakse kuupäev

27. mai 2025

Järgmine aktsia dividendi kuupäev (ex-date)

11. aug 2025

Turustatistika

By TradingEconomics

Turukapital

9.9B

116B

Eelmine avamishind

125.63

Eelmine sulgemishind

125.83

Uudiste sentiment

By Acuity

21%

79%

45 / 540 Pingereas Finance

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

KKR & Co LP Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. mai 2025, 14:11 UTC

Tulu

KKR Swings to 1Q Loss, Asset Management Sales Rise

30. apr 2025, 14:14 UTC

Omandamised, ülevõtmised, äriostud

GlobalData Gets Takeover Approaches From KKR, ICG Europe Fund

22. apr 2025, 06:50 UTC

Omandamised, ülevõtmised, äriostud

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14. apr 2025, 11:46 UTC

Omandamised, ülevõtmised, äriostud

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9. apr 2025, 10:24 UTC

Omandamised, ülevõtmised, äriostud

EQT to Sell Karo Healthcare to KKR

9. apr 2025, 07:09 UTC

Omandamised, ülevõtmised, äriostud

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9. apr 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7. apr 2025, 14:42 UTC

Omandamised, ülevõtmised, äriostud

Assura Agrees to Primary Health Properties Bid Deadline Extension

1. mai 2025, 10:55 UTC

Tulu

KKR Declares Qtrly Div of 18.5/Share >KKR

1. mai 2025, 10:54 UTC

Tulu

KKR 1Q Rev $3.11B >KKR

1. mai 2025, 10:54 UTC

Tulu

KKR 1Q Insurance Revenue $1.06B >KKR

1. mai 2025, 10:54 UTC

Tulu

KKR 1Q Asset-Management and Strategic Holdings Revenue $2.05B >KKR

1. mai 2025, 10:54 UTC

Tulu

KKR 1Q-End Assets Under Management $664B >KKR

1. mai 2025, 10:54 UTC

Tulu

KKR 1Q Fee-Related Earnings $823M, or 92c/Adj. Share >KKR

1. mai 2025, 10:53 UTC

Tulu

KKR 1Q Loss/Shr 22c >KKR

22. apr 2025, 06:04 UTC

Omandamised, ülevõtmised, äriostud

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22. apr 2025, 06:03 UTC

Omandamised, ülevõtmised, äriostud

KKR: Biotage Board Recommends Shareholders Accept Offer

22. apr 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

KKR: Offer Values Biotage at SEK11.61B

22. apr 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

KKR Makes SEK145 a Share Bid For Biotage

18. apr 2025, 00:00 UTC

Peamised uudised

Private Equity World Engulfed by Perfect Storm -- WSJ

14. apr 2025, 11:31 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14. apr 2025, 11:02 UTC

Omandamised, ülevõtmised, äriostud

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14. apr 2025, 11:01 UTC

Omandamised, ülevõtmised, äriostud

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14. apr 2025, 11:00 UTC

Omandamised, ülevõtmised, äriostud

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14. apr 2025, 11:00 UTC

Omandamised, ülevõtmised, äriostud

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11. apr 2025, 11:56 UTC

Omandamised, ülevõtmised, äriostud

KKR Now Owns 30% of Enilive

11. apr 2025, 11:55 UTC

Omandamised, ülevõtmised, äriostud

KKR Completes Acquisition of Additional Stake in Enilive

9. apr 2025, 09:51 UTC

Omandamised, ülevõtmised, äriostud

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9. apr 2025, 09:32 UTC

Omandamised, ülevõtmised, äriostud

EQT: Transaction Expected to Close in Coming Months

9. apr 2025, 09:31 UTC

Omandamised, ülevõtmised, äriostud

EQT to Sell Karo Healthcare to KKR

Võrdlus sarnastega

Hinnamuutus

KKR & Co LP Prognoos

Hinnasiht

By TipRanks

9.8% tõus

12 kuu keskmine prognoos

Keskmine 141.67 USD  9.8%

Kõrge 194 USD

Madal 119 USD

Põhineb 12 Wall Streeti analüütiku instrumendi KKR & Co LP 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

12 ratings

12

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

114.51 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Neutral Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

45 / 540 Pingereas Rahandus

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m